Projects funded by the NCN

Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m...

Call: HARMONIA 6 , Panel: NZ5

Principal investigator: dr Tomasz Stokłosa

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Inhibition of p21-Activated Kinase (PAK) as a new molecular target in the treatment of chronic myeloid leukemia (CML)

Call: OPUS 6 , Panel: NZ7

Principal investigator: dr hab. Sylwia Flis

Narodowy Instytut Leków

The novel role of CD44 protein in the bone marrow microenvironment-mediated metabolic remodeling of chronic myeloid leuk...

Call: PRELUDIUM 22 , Panel: NZ3

Principal investigator: Laura Turos-Korgul

Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

Linking stress response with genomic instability in chronic myeloid leukaemia cells; role of the PERK-eIF2α phosphorylat...

Call: OPUS 1 , Panel: NZ3

Principal investigator: dr hab. Katarzyna Piwocka

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Immunological and molecular characteisitics of chronic myeloid leukemia patients after stopping imatinib

Call: OPUS 16 , Panel: NZ6

Principal investigator: prof. Krzysztof Giannopoulos

Uniwersytet Medyczny w Lublinie, Wydział Lekarski

Phosphorylation of translation initiation factor eIF2alpha as regulator of synthesis of proinflammatory and signaling cy...

Call: PRELUDIUM 10 , Panel: NZ3

Principal investigator: Wioleta Dudka-Ruszkowska

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

Characterization of aberrant mechanisms of telomere maintenance in chronic myeloid leukemia - the role of POT1 and RAP1 ...

Call: OPUS 10 , Panel: NZ5

Principal investigator: dr Tomasz Stokłosa

Warszawski Uniwersytet Medyczny, Wydział Lekarski